- Nutex Health (NASDAQ:NUTX) said on Friday it had received a Nasdaq notice stating that due to the company’s non-compliance with Nasdaq’s listing rules, NUTX’s common stock would be scheduled for delisting from Nasdaq and would be suspended for trading at the opening of business on May 30, unless the company timely requests a hearing before an independent Nasdaq Hearings Panel by May 28, 2024.
- According to the Nasdaq notice, NUTX was not in compliance with the minimum $1.00 bid price requirement set forth in Nasdaq listing rules.
- Press Release
